Medicine & Life Sciences
Isoprostanes
100%
Eicosapentaenoic Acid
83%
Aspartic Acid
71%
Radiology
68%
Neurotransmitter Agents
59%
Retina
59%
ramatroban
32%
Prostaglandins
32%
Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide
31%
Receptors, Prostaglandin E, EP1 Subtype
30%
SQ 29548
29%
6-isopropoxy-9-oxoxanthene-2-carboxylic acid
29%
ozagrel
27%
F2-Isoprostanes
25%
Thromboxane Receptors
24%
3-(p-(alpha-(p-methoxyphenyl)beta-nitrostyryl)phenoxy)-N,N-dimethylpropylamine monocitrate
24%
Flurbiprofen
24%
Thromboxanes
20%
Cyclooxygenase Inhibitors
20%
Prostaglandin-Endoperoxide Synthases
18%
Arachidonic Acid
17%
Mammals
15%
Biopsy
13%
Thyroid Nodule
13%
Lost to Follow-Up
12%
Pharmacology
11%
Radiologists
10%
Compliance
10%
Communication
8%
Chemical Compounds
Neurotransmitter
75%
Prostanoid
73%
Metabolite
48%
Ozagrel
33%
EC 1.14.99.1 (Prostaglandin-Endoperoxide Synthase) Inhibitor
25%
Flurbiprofen
24%
Thromboxane
24%
Retinal
19%
Agent Interacting With Transmitter, Hormone or Drug Receptor
18%
Arachidonic Acid
18%
Antagonist
15%